China approves J&J's oral psoriasis pill, says drugmaker

JNJ•2026-08-27

China approves icotrokinra for plaque psoriasis

SHANGHAI, Aug. 27 (Reuters) - Johnson & Johnson said on Thursday that its oral drug icotrokinra was approved in China for moderate-to-severe plaque psoriasis.

China approves J&J's oral psoriasis pill, says drugmaker

China approves icotrokinra for plaque psoriasis

Related News

Philippine assets remain weak after rate hike; Asian stocks gain on Nvidia beat

Nasdaq trade halt continues <FBRX.O> reason not available at 03:58 AM

Salesforce rises after higher forecasts, Claude AI plug-in

Kioxia CEO Ota: Kioxia and Sandisk to invest 5 trln yen over next 6 yrs including investment in new production facility

World stocks steady as Nvidia outlook lifts tech shares